Giuseppe Cullaro1, Jessica Rubin1, Neil Mehta1, Francis Yao1, Elizabeth C Verna2, Jennifer C Lai1. 1. Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, CA. 2. Center for Liver Disease and Transplantation, Columbia University, College of Physicians and Surgeons, New York, NY.
Abstract
BACKGROUND: Women with chronic liver disease have lower rates of hepatocellular carcinoma (HCC) as compared to men; it is unknown if there are sex-based differences in HCC recurrence postliver transplant. METHODS: We conducted an analysis of patients who underwent liver transplant for HCC in the United Network for Organ Sharing/Organ Procurement and Transplantation Network from January 1, 2012 through December 31, 2017. RESULTS: A total of 12 711 patients underwent liver transplant for HCC: 2909 (23%) women and 9802 (73%) men. Women had significantly lower rates of postliver transplant HCC recurrence than men (4.0% versus 5.4%, P = 0.002). A cox-regression analysis for postliver transplant HCC recurrence highlighted that even after accounting for etiology of cirrhosis, alpha-fetoprotein at liver transplant, tumor diameter, tumor pathology, and vascular invasion, female sex was associated with a 25% lower risk of postliver transplant HCC recurrence (95% confidence interval: 0.57-0.99). There were no interactions between female sex and the following variables: age, type of locoregional therapy, alpha-fetoprotein, donor sex, body mass index, or nonalcoholic steatohepatitis etiology (P > 0.05 for each). CONCLUSIONS: This study demonstrates an independent effect of sex on risk for HCC recurrence postliver transplant. Our data highlight an opportunity to better understand HCC tumor biology by investigating the drivers of this sex-based difference in HCC recurrence.
BACKGROUND: Women with chronic liver disease have lower rates of hepatocellular carcinoma (HCC) as compared to men; it is unknown if there are sex-based differences in HCC recurrence postliver transplant. METHODS: We conducted an analysis of patients who underwent liver transplant for HCC in the United Network for Organ Sharing/Organ Procurement and Transplantation Network from January 1, 2012 through December 31, 2017. RESULTS: A total of 12 711 patients underwent liver transplant for HCC: 2909 (23%) women and 9802 (73%) men. Women had significantly lower rates of postliver transplant HCC recurrence than men (4.0% versus 5.4%, P = 0.002). A cox-regression analysis for postliver transplant HCC recurrence highlighted that even after accounting for etiology of cirrhosis, alpha-fetoprotein at liver transplant, tumor diameter, tumor pathology, and vascular invasion, female sex was associated with a 25% lower risk of postliver transplant HCC recurrence (95% confidence interval: 0.57-0.99). There were no interactions between female sex and the following variables: age, type of locoregional therapy, alpha-fetoprotein, donor sex, body mass index, or nonalcoholic steatohepatitis etiology (P > 0.05 for each). CONCLUSIONS: This study demonstrates an independent effect of sex on risk for HCC recurrence postliver transplant. Our data highlight an opportunity to better understand HCC tumor biology by investigating the drivers of this sex-based difference in HCC recurrence.
Authors: Ju Dong Yang; Joseph J Larson; Kymberly D Watt; Alina M Allen; Russell H Wiesner; Gregory J Gores; Lewis R Roberts; Julie A Heimbach; Michael D Leise Journal: Clin Gastroenterol Hepatol Date: 2016-12-21 Impact factor: 11.382
Authors: Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin Journal: Science Date: 2007-07-06 Impact factor: 47.728
Authors: Mariya L Samoylova; Jennifer L Dodge; Eric Vittinghoff; Francis Y Yao; John Paul Roberts Journal: Liver Transpl Date: 2013-10-21 Impact factor: 5.799
Authors: Vincenzo Mazzaferro; Carlo Sposito; Jian Zhou; Antonio D Pinna; Luciano De Carlis; Jia Fan; Matteo Cescon; Stefano Di Sandro; He Yi-Feng; Andrea Lauterio; Marco Bongini; Alessandro Cucchetti Journal: Gastroenterology Date: 2017-10-05 Impact factor: 22.682
Authors: M Trinidad Serrano; Sergio Sabroso; Luis M Esteban; Marina Berenguer; Constantino Fondevila; Sara Lorente; Luis Cortés; Gloria Sanchez-Antolin; Javier Nuño; Gloria De la Rosa; Magdalena Salcedo Journal: Transpl Int Date: 2022-05-09 Impact factor: 3.842